David P. Hochman - 14 Nov 2025 Form 4 Insider Report for Orchestra BioMed Holdings, Inc. (OBIO)

Role
Chief Executive Officer and Chairperson, Director
Signature
/s/ Andrew Taylor, Attorney-in-Fact
Issuer symbol
OBIO
Transactions as of
14 Nov 2025
Transactions value $
$20,350
Form type
4
Filing time
17 Nov 2025, 17:00:21 UTC
Previous filing
14 Nov 2025
Next filing
12 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hochman David P Chief Executive Officer and Chairperson, Director C/O ORCHESTRA BIOMED HOLDINGS, INC., 150 UNION SQUARE DRIVE, NEW HOPE /s/ Andrew Taylor, Attorney-in-Fact 17 Nov 2025 0001292834

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OBIO Common Stock, par value $0.0001 per share ("Common Stock") Purchase $20.4K +5K +0.82% $4.07 613K 14 Nov 2025 Direct F1
holding OBIO Common Stock 443K 14 Nov 2025 By the DPH 2008 Trust
holding OBIO Common Stock 2K 14 Nov 2025 By the Solomon Ascher Hochman 2019 Trust
holding OBIO Common Stock 2K 14 Nov 2025 By the Hannah Hochman 2019 Trust
holding OBIO Common Stock 2K 14 Nov 2025 By the Judah Herman Hochman 2019 Trust
holding OBIO Common Stock 3.14K 14 Nov 2025 By the NSH 2008 Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.06 to $4.10. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Remarks:

Chief Executive Officer and Chairperson